GBLB Stock Analysis: Groep Brussel Lambert | BR
Asset Management | BR, Belgium | Market Cap: 8.396m EUR | 12M Return: -4.4% | BE0003797140 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 6.72M
Rev. Trend: 4.7%
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Groupe Bruxelles Lambert SA (GBLB) is a Belgian investment holding company that manages a diversified portfolio of industrial, consumer goods, and business service companies across Belgium, Europe, North America, and other international markets. The company operates through six reportable segments: Holding, Imerys, Canyon, Affidea, Sanoptis, and GBL Capital and Sienna Investment Managers, reflecting a mix of direct operating businesses and asset management activities. Founded in 1902 and headquartered in Brussels, GBL is classified within the Financials sector under the Multi-Sector Holdings sub-industry, with a large-cap market capitalization.
As a long-established holding company, GBL follows the classic investment holding model typical of Belgian holding structures, where a single listed entity owns controlling or significant stakes in multiple operating subsidiaries and associates, allowing investors indirect exposure to a diversified set of industries through one share. Multi-sector holdings typically focus on long-term value creation through capital allocation, strategic oversight, and selective acquisitions or divestitures across their portfolio companies.
- Imerys lithium and minerals segment drives portfolio valuation
- Canyon e-bike demand and Affidea healthcare expansion boost growth
- NAV discount narrows on share buybacks and portfolio rebalancing
| Net Income: -499.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -2.64 > 1.0 |
| NWC/Revenue: 21.20% < 20% (prev 44.97%; Δ -23.78% < -1%) |
| CFO/TA 0.03 > 3% & CFO 747.1m > Net Income -499.9m |
| Net Debt (6.93b) to EBITDA (767.0m): 9.04 < 3 |
| Current Ratio: 4.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (121.3m) vs 12m ago -6.88% < -2% |
| Gross Margin: 55.97% > 18% (prev 45.05%; Δ 10.93% > 0.5%) |
| Asset Turnover: 35.22% > 50% (prev 23.84%; Δ 11.38% > 0%) |
| Interest Coverage Ratio: 0.08 > 6 (EBIT TTM 26.2m / Interest Expense TTM 316.8m) |
| A: 0.08 (Total Current Assets 2.39b - Total Current Liabilities 537.9m) / Total Assets 24.0b |
| B: 0.24 (Retained Earnings 5.76b / Total Assets 24.0b) |
| C: 0.00 (EBIT TTM 26.2m / Avg Total Assets 24.8b) |
| D: 0.92 (Book Value of Equity 10.7b / Total Liabilities 11.6b) |
| Altman-Z'' = 2.26 = BBB |
| DSRI: 0.77 (Receivables 838.1m/756.1m, Revenue 8.72b/6.09b) |
| GMI: 0.80 (GM 45.05% / 55.97%) |
| AQI: 1.16 (AQ_t 0.75 / AQ_t-1 0.65) |
| SGI: 1.43 (Revenue 8.72b / 6.09b) |
| TATA: -0.05 (NI -499.9m - CFO 747.1m) / TA 24.0b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of October 07, 2026, the stock is trading at EUR 69.20 with a total of 115,273 shares traded. Over the past week, the price has changed by -4.42%, over one month by -6.55%, over three months by -12.13% and over the past year by -4.35%.
Current recommended Stop Loss: 67.70 (which is 2.2% or 1.5 ATR below the current price).
Groep Brussel Lambert has no consensus analysts rating.
P/E Forward = 25.7069
P/S = 1.2687
P/B = 0.8124
P/EG = 0.5212
Revenue TTM = 8.72b EUR
EBIT TTM = 26.2m EUR
EBITDA TTM = 767.0m EUR
Long Term Debt = 6.34b EUR (from longTermDebt, last quarter)
Short Term Debt = 537.9m EUR (from shortTermDebt, last quarter)
Debt = 8.48b EUR (from shortLongTermDebtTotal, last quarter) + Leases 867.9m
Net Debt = 6.93b EUR (calculated: Debt 8.48b - CCE 1.55b)
Enterprise Value = 15.3b EUR (8.40b + Debt 8.48b - CCE 1.55b)
Interest Coverage Ratio = 0.08 (Ebit TTM 26.2m / Interest Expense TTM 316.8m)
EV/FCF = 222.1x (Enterprise Value 15.3b / FCF TTM 69.0m)
FCF Yield = 0.45% (FCF TTM 69.0m / Enterprise Value 15.3b)
FCF Margin = 0.79% (FCF TTM 69.0m / Revenue TTM 8.72b)
Net Margin = -5.73% (Net Income TTM -499.9m / Revenue TTM 8.72b)
Gross Margin = 55.97% ((Revenue TTM 8.72b - Cost of Revenue TTM 3.84b) / Revenue TTM)
Gross Margin QoQ = 53.18% (prev 72.41%)
Tobins Q-Ratio = 0.64 (Enterprise Value 15.3b / Total Assets 24.0b)
Interest Expense / Debt = 3.74% (Interest Expense 316.8m / Debt 8.48b)
Taxrate = 32.01% (33.9m / 105.9m)
NOPAT = 17.8m (EBIT 26.2m * (1 - 32.01%))
Current Ratio = 4.44 (Total Current Assets 2.39b / Total Current Liabilities 537.9m)
Debt / Equity = 0.79 (Debt 8.48b / totalStockholderEquity, last quarter 10.7b)
Debt / EBITDA = 9.04 (Net Debt 6.93b / EBITDA 767.0m)
Debt / FCF = 100.5 (Net Debt 6.93b / FCF TTM 69.0m)
Total Stockholder Equity = 12.5b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.02% (Net Income -499.9m / Total Assets 24.0b)
RoE = -4.00% (Net Income TTM -499.9m / Total Stockholder Equity 12.5b)
RoCE = 0.14% (EBIT 26.2m / Capital Employed (Equity 12.5b + L.T.Debt 6.34b))
RoIC = 0.08% (NOPAT 17.8m / Invested Capital 23.6b)
WACC = 4.77% (E(8.40b)/V(16.9b) * Re(7.03%) + D(8.48b)/V(16.9b) * Rd(3.74%) * (1-Tc(0.32)))
Discount Rate = 7.03% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -61.59 | Cagr: -6.06%
[DCF] Terminal Value 73.10% ; FCFF base≈340.2m ; Y1≈298.3m ; Y5≈241.0m
[DCF] Fair Price = N/A (negative equity: EV 3.87b - Net Debt 6.93b = -3.06b; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 4.71 | Revenue CAGR: 0.75% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=2.82 | Chg30d=+20.00% | Revisions=+25% | GrowthEPS=-1.4% | GrowthRev=+2.6%
EPS next Year (2027-12-31): EPS=2.83 | Chg30d=+19.41% | Revisions=+25% | GrowthEPS=+0.4% | GrowthRev=+3.0%